Parataxis Holdings 'Bitcoinizes' Bridge Biotherapeutics, Opening a New Era of Public BTC Treasury in South Korea

Parataxis Holdings has just announced the acquisition of Bridge Biotherapeutics for 25 billion won (~18.5 million USD) to transform this listed company into the first public Bitcoin treasury in South Korea.

#ParataxisHoldings is a digital asset investment company based in New York, specializing in developing Bitcoin accumulation strategies. Through this deal, the company will rename Bridge Bio to Parataxis Korea and bring the BTC treasury model to institutional investors in South Korea.

The new CEO of Parataxis Korea – Mr. Andrew Kim – stated:

'South Korea is the next strategic link in the global Bitcoin treasury wave.'

Meanwhile, founder Edward Chin emphasized that $BTC is increasingly becoming a global financial pillar and Parataxis Korea will create long-term value for shareholders and the economy.

Immediately after the acquisition announcement, Bridge Bio's (288330.KQ) stock surged nearly 40% over 5 sessions, reflecting strong investor confidence.

Parataxis also revealed that it is preparing additional specialized investment funds following the Bitcoin treasury model, expanding into other markets.

📌 Investor Warning: The trend of public companies accumulating BTC is a positive long-term trend, but investors should also be cautious of security risks, cold wallet governance, and the high price volatility of Bitcoin. #Korea